ArticleOncogene2019
Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma.
Makoto Nakagawa et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
47 papers cite it
this papertrialcites it